Luzerner Kantonalbank AG Share Price

Certificat

LLVHLK

CH1181313813

Real-time Bid/Ask 01:23:02 10/06/2024 pm IST
109.65 EUR / 110.48 EUR +0.41% Intraday chart for Luzerner Kantonalbank AG
1 month+0.73%
3 months+2.16%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
05/24/05 109.6 +0.04%
04/24/04 109.6 +0.03%
03/24/03 109.6 +0.03%

Delayed Quote Swiss Exchange

Last update June 05, 2024 at 08:50 pm IST

More quotes

Static data

Product typeObligations Convertibles
Buy / SellCALL
Underlying ROCHE HOLDING AG
Issuer Luzerner Kantonalbank AG
LLVHLK
ISINCH1181313813
Date issued 02/02/2023
Strike 273.8 CHF
Maturity 02/08/2024 (54 Days)
Parity 0.09 : 1
Emission price 100
Emission volume N/A
Settlement les deux
Currency EUR

Technical Indicators

Highest since issue 109.6
Lowest since issue 99.18
Spread 8.3
Spread %0.75%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
242.6 CHF
Average target price
277.5 CHF
Spread / Average Target
+14.40%
Consensus
  1. Stock Market
  2. Certificates
  3. LLVHLK Certificat